Accolade Inc
(NAS:ACCD)
$
6.145
0.18 (3.02%)
Market Cap: 491.65 Mil
Enterprise Value: 496.27 Mil
PE Ratio: 0
PB Ratio: 1.08
GF Score: 71/100 - Q4 2024 Accolade Inc Earnings Call TranscriptApr 25, 2024$9.19 (-2.23%)Earnings
- Accolade Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2024 Accolade Inc Earnings Call TranscriptJan 08, 2024$11.62 (+4.31%)Earnings
- Q2 2024 Accolade Inc Earnings Call TranscriptOct 04, 2023$9.75 (-3.56%)Earnings
- Accolade Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q1 2024 Accolade Inc Earnings Call TranscriptJun 29, 2023$12.64 (+0.24%)Earnings
- Accolade Inc at Stifel Cross Sector Insight Conference TranscriptJun 06, 2023
- Accolade Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Accolade Inc Investor Day TranscriptMay 08, 2023
- Q4 2023 Accolade Inc Earnings Call TranscriptApr 27, 2023$16.06 (+0.37%)Earnings
- Q3 2023 Accolade Inc Earnings Call TranscriptJan 09, 2023$7.74 (+4.17%)Earnings
- Q2 2023 Accolade Inc Earnings Call TranscriptOct 06, 2022$12.39 (-0.72%)Earnings
- Accolade Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q1 2023 Accolade Inc Earnings Call TranscriptJun 30, 2022$7.4 (-7.85%)Earnings
- Accolade Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q4 2022 Accolade Inc Earnings Call TranscriptApr 28, 2022$11.06 (-9.93%)Earnings
- Q3 2022 Accolade Inc Earnings Call TranscriptJan 10, 2022$19.14 (-8.51%)Earnings
- Accolade Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2021
- Q2 2022 Accolade Inc Earnings Call TranscriptOct 07, 2021$39.93 (-0.42%)Earnings
- Accolade Inc At EVOLVE Q&A Call TranscriptSep 21, 2021
- Accolade Inc At EVOLVE Keynote Call TranscriptSep 21, 2021
- Accolade Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q1 2022 Accolade Inc Earnings Call TranscriptJul 08, 2021$52.36 (-1.04%)Earnings
- Accolade Inc at Stifel Cross Sector Insight Conference (Virtual) TranscriptJun 10, 2021
- Accolade Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Accolade Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q4 2021 Accolade Inc Earnings Call TranscriptMay 05, 2021$45.05 (-2.51%)Earnings
- Accolade Inc Acquisition of PlushCare Inc M&A Call TranscriptApr 23, 2021
- Accolade Inc to Acquire 2nd.MD TranscriptJan 14, 2021
- Accolade Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2021 Accolade Inc Earnings Call TranscriptJan 07, 2021$46.92 (+6.52%)Earnings
- Accolade Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2020
- Q2 2021 Accolade Inc Earnings Call TranscriptOct 14, 2020$44.49 (+1.23%)Earnings
- Q1 2021 Accolade Inc Earnings Call TranscriptAug 13, 2020$37.27 (-0.96%)Earnings
Accolade Inc at Stifel Cross Sector Insight Conference Transcript
Jun 06, 2023 / 03:30PM GMT
Release Date Price:
$13.67
(+6.63%)
David Grossman
Stifel Financial Corp. - Analyst
Good morning. My name is David Grossman, and welcome to the Accolade presentation. With us today, we have to my right, Steve Barnes, the company's CFO; and to his right, Todd Friedman, Senior Vice President and Head of Investor Relations. So the way we're going to run today, totally interactive. If you have any questions, feel free to chime in.
But I think we're going to start with a video, right?
Steve Barnes
Accolade, Inc. - CFO
Yes.
Todd Friedman
Accolade, Inc. - IR
Yeah.
David Grossman
Stifel Financial Corp. - Analyst
So you guys on the back, do we have that video ready to go?
Todd Friedman
Accolade, Inc. - IR
I got it.
David Grossman
Stifel Financial Corp. - Analyst
You got it?
Todd Friedman
Accolade, Inc. - IR
It's going to [run] in the presentation.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)